---
title: "Endospan completes enrolment of primary arm in TRIOMPHE IDE clinical study"
date: "2024-10-21T12:41:44.000Z"
publishedDate: "21 octobre 2024"
summary: "Endospan today announced the completion of enrolment for the primary arm of its TRIOMPHE investigational device exemption (IDE) clinical study investigating the Nexus aortic arch stent graft. The study is evaluating the safety and efficacy of the device for the treatment of aortic arch disease."
importance: ""
sourceUrl: "https://vascularnews.com/endospan-completes-enrolment-of-primary-arm-in-triomphe-ide-clinical-study/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2024-10-21-endospan-completes-enrolment-of-primary-arm-in-triomphe-ide-clinical-study"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2019/09/Nexus-stent-graft-system-web.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/endospan-completes-enrolment-of-primary-arm-in-triomphe-ide-clinical-study/"
---

![Endospan completes enrolment of primary arm in TRIOMPHE IDE clinical study](https://vascularnews.com/wp-content/uploads/sites/7/2019/09/Nexus-stent-graft-system-web.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/endospan-completes-enrolment-of-primary-arm-in-triomphe-ide-clinical-study/*

## L’essentiel

Endospan today announced the completion of enrolment for the primary arm of its TRIOMPHE investigational device exemption (IDE) clinical study investigating the Nexus aortic arch stent graft. The study is evaluating the safety and efficacy of the device for the treatment of aortic arch disease.

## Lien source

https://vascularnews.com/endospan-completes-enrolment-of-primary-arm-in-triomphe-ide-clinical-study/
